View more information about ongoing clinical trials. »
UC Irvine Dermatology Clinical Research Center (DCRC) conducts innovative studies dedicated to evaluating and improving novel therapeutic options for a variety of skin conditions in adults and children. In addition to our research with pharmaceuticals, we also investigate new therapeutic uses of light technology and other medical devices. Onsite individual and multi-center clinical trials are implemented for major pharmaceutical and cosmetic companies, as well as investigator initiated studies. The DCRC is actively involved in all phases of clinical testing including FDA approval of investigational drugs and lasers, new indications for drugs, over-the-counter products and cosmeceuticals.
Previous studies include investigations on psoriasis, acne, acne scars, atopic dermatitis, eczema, rosacea, actinic keratosis, skin cancer, seborrheic dermatitis, hair and nail disorders, alopecia, photoaging, cellulite, port wine stain and hemangioma. UC Irvine has conducted various light technology trials using the pulsed dye laser, photodynamic therapy, fractionated CO2 laser, and 1064 nm Nd:YAG laser. Studies are conducted at Hewitt Hall and the Beckman Laser Institute at the UC Irvine campus and at The Dermatology Center in Irvine.
The Dermatology Clinical Research Center is currently conducting investigations on the following dermatologic conditions: